FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Correction on Opioids Hearing

[ Price : $8.95]

Federal Register notice correction: FDA corrects a 6/21 notice entitled Standards for Future Opioid Analgesic Approvals and Incent...

Indian Pharmas Receive 33% of WLs This Year: Analysis

[ Price : $8.95]

The environmental publication Down to Earth says Indian drug companies received 13 of the 38 Warning Letters FDA has issued so far...

CDRH Regulatory Science Priorities

[ Price : $8.95]

CDRH releases its list of 10 current regulatory science priorities.

More FDA Stem Cell Steps Needed: Pew

[ Price : $8.95]

A Pew Charitable Trusts report says FDA should do more to deter businesses from selling stem cell interventions whose safety and e...

BeiGene NDA for Mantle Cell Lymphoma Drug

[ Price : $8.95]

FDA accepts for priority review a BeiGene NDA for zanubrutinib for treating patients with mantle cell lymphoma who have received a...

SurGenTec Alara Neuro Access Needle Kit Cleared

[ Price : $8.95]

FDA clears a SurGenTec 510(k) for a neurostimulation indication for their Alara Neuro Access Needle Kit.

Indian API Maker Hit with Form FDA-483

[ Price : $8.95]

Indian active pharmaceutical ingredients maker Shilpa Medicare gets a five-observation Form FDA-483 after an inspection concluded ...

Medical Groups Want FDA Compounding Discretion

[ Price : $8.95]

21 physician organizations ask FDA not to finalize a guidance on insanitary conditions in drug compounding facilities in a way tha...

Zonegran Not Withdrawn Due to Safety/Efficacy: FDA

[ Price : $8.95]

Federal Register notice: FDA determines that Sunovion Pharmaceuticals Zonegran (zonisamide) was not withdrawn for safety or effect...

Trump Orders VA Spravato Purchase

[ Price : $8.95]

President Donald Trump orders the Veterans Administration to obtain supplies of Johnson & Johnsons Spravato for use with suicidal ...